• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Catheter Cardiovasc Interv. Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian

tetano

Editor, Senior Moderator
Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889. [Epub ahead of print]
Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.


Sadeghipour P[SUP]1[/SUP], Talasaz AH[SUP]2[/SUP], Eslami V[SUP]3[/SUP], Gerayeli B[SUP]4[/SUP], Vojdanparast M[SUP]5[/SUP], Sedaghat M[SUP]6[/SUP], Moosavi AF[SUP]7[/SUP], Alipour-Parsa S[SUP]3[/SUP], Aminian B[SUP]8[/SUP], Firouzi A[SUP]1[/SUP], Ghafari S[SUP]9[/SUP], Ghasemi M[SUP]4[/SUP], Saleh DK[SUP]10[/SUP], Khosravi A[SUP]11[/SUP], Kojuri J[SUP]8[/SUP], Noohi F[SUP]1[/SUP], Pourhosseini H[SUP]2[/SUP], Salarifar M[SUP]2[/SUP], Salehi MR[SUP]12[/SUP], Sezavar H[SUP]13[/SUP], Shabestari M[SUP]5[/SUP], Soleimani A[SUP]14[/SUP], Tabarsi P[SUP]15[/SUP], Parsa AFZ[SUP]4[/SUP], Abdi S[SUP]1[/SUP].

Author information




Abstract

World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it.
? 2020 Wiley Periodicals, Inc.



KEYWORDS:

acute myocardial infarction/STEMI; percutaneous coronary intervention; thrombolytic therapy


PMID:32320138DOI:10.1002/ccd.28889
 
Back
Top Bottom